(Q31044140)

English

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

0 references

type 2 diabetes

1 reference

based on heuristic

inferred from title

6

object named as

E Franek

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

author name string

L Masmiquel

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

L A Leiter

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J Vidal

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

S Bain

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J Petrie

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

I Raz

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A Comlekci

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

S Jacob

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

L van Gaal

10

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

F M M Baeres

11

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

S P Marso

12

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

M Eriksson

13

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

LEADER investigators

14

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

10 February 2016

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Cardiovascular Diabetology

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

15

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

29

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Association of obesity with glucose, blood pressure, and lipid goals attainment in patients with concomitant diabetes and hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Ethnicity-specific obesity cut-points in the development of Type 2 diabetes - a prospective study including three ethnic groups in the United Kingdom

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Anthropometric measurements of general and central obesity and the prediction of cardiovascular disease risk in women: a cross-sectional study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Overview of epidemiology and contribution of obesity to cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Association between obesity and therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Standards of medical care in diabetes--2014

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Important treatment gaps in vascular protection for the elderly after type 2 diabetes therapy initiation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Personal attributes that influence the adequate management of hypertension and dyslipidemia in patients with type 2 diabetes. Results from the DIAB-CORE Cooperation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Predictors of mortality over 8 years in type 2 diabetic patients: Translating Research Into Action for Diabetes (TRIAD)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

The global obesity pandemic: shaped by global drivers and local environments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Relation Between Obesity and the Attainment of Optimal Blood Pressure and Lipid Targets in High Vascular Risk Outpatients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Relationships of obesity and fat distribution with atherothrombotic risk factors: baseline results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Statins and cardioprotection--more than just lipid lowering?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

The relationship of body fat to metabolic disease: influence of sex and ethnicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Burden and rates of treatment and control of cardiovascular disease risk factors in obesity: the Framingham Heart Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4750199

28 July 2018

Is there a paradox in obesity?

1 reference

https://api.crossref.org/works/10.1186%2FS12933-016-0341-5

21 January 2018

Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial.

1 reference

https://api.crossref.org/works/10.1186%2FS12933-016-0341-5

21 January 2018

Ethnic-specific obesity cutoffs for diabetes risk: cross-sectional study of 490,288 UK biobank participants

1 reference

https://api.crossref.org/works/10.1186%2FS12933-016-0341-5

21 January 2018

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

1 reference

https://api.crossref.org/works/10.1186%2FS12933-016-0341-5

21 January 2018

Points for improvement: performance measurement for glycemic control in diabetes patients in a safety-net population

1 reference

https://api.crossref.org/works/10.1186%2FS12933-016-0341-5

21 January 2018

Do men develop type 2 diabetes at lower body mass indices than women?

1 reference

https://api.crossref.org/works/10.1186%2FS12933-016-0341-5

21 January 2018

Gender differences and patterns of cardiovascular risk factors in Type 1 and Type 2 diabetes: a population-based analysis from a Scottish region.

1 reference

https://api.crossref.org/works/10.1186%2FS12933-016-0341-5

21 January 2018

Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).

1 reference

https://api.crossref.org/works/10.1186%2FS12933-016-0341-5

21 January 2018

Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme.

1 reference

https://api.crossref.org/works/10.1186%2FS12933-016-0341-5

21 January 2018

Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial

1 reference

https://api.crossref.org/works/10.1186%2FS12933-016-0341-5

21 January 2018

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

1 reference

https://api.crossref.org/works/10.1186%2FS12933-016-0341-5

21 January 2018

Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.1186%2FS12933-016-0341-5

21 January 2018

Patients With Type 2 Diabetes Show a Greater Decline in Muscle Mass, Muscle Strength, and Functional Capacity With Aging

1 reference

https://api.crossref.org/works/10.1186%2FS12933-016-0341-5

21 January 2018

Risk Factor Control for Coronary Artery Disease Secondary Prevention in Large Randomized Trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/26864124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic mediators of body-mass index and cardiovascular risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/26864124

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S12933-016-0341-5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31044140&oldid=2195073654"